A single centre, randomised controlled, open label study of rituximab as induction therapy in kidney transplantatio

Not Applicable

Completed

• Conditions: Immunosuppression following renal transplantation; Kidney transplant; Surgery

• Registration Number: ISRCTN07963178
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05-10
• Last Update Posted: 9 October 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients undergoing renal transplantation

Exclusion Criteria

Age under 18 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified